Business Context and Reporting Period
This Form 8-K is a current report filed by Centene Corporation on February 23, 2026. The filing serves as a Regulation FD disclosure regarding an upcoming investor meeting scheduled for the week of February 23, 2026. The document reaffirms the company's full-year 2026 financial guidance previously issued on February 6, 2026.
Key Financial Metrics
The filing does not provide specific historical revenue, profit, cash flow, margin, debt, or liquidity figures for the current or prior periods. It focuses exclusively on forward-looking earnings per share (EPS) targets:
- 2026 Full Year GAAP Diluted EPS Guidance: Greater than $1.98
- 2026 Full Year Adjusted Diluted EPS Guidance: Greater than $3.00
The company utilizes non-GAAP measures to exclude amortization of acquired intangible assets, acquisition/divestiture expenses, and other items to better reflect core operational performance.
Material Changes
The filing does not report material changes to financial results or operations compared to prior periods. The primary update is the reaffirmation of the 2026 full-year guidance originally provided on February 6, 2026, indicating no downward or upward revision to the targets at this time.
Guidance, Outlook, and Risks
Management Commentary and Outlook: Senior management plans to reaffirm the 2026 EPS targets during investor meetings. The company emphasizes that these forward-looking statements are based on current assumptions and are not guarantees of future performance.
Key Risks and Contingencies: The filing outlines extensive risks that could cause actual results to differ materially from guidance, including:
- Changes in federal or state laws, regulations, and funding for government-sponsored healthcare programs (e.g., ACA, Medicaid, Medicare).
- Fluctuations in medical costs, inflation, and provider behaviors.
- Rate cuts or payment reductions by government payors.
- Regulatory audits, investigations, and contract reprocurement challenges.
- Macroeconomic conditions, including interest rates and geopolitical events.
- Cyber-attacks, data security incidents, and operational disruptions.
- Changes in CMS Star ratings and quality scores.
Investor Verification Checklist
- Verify the reconciliation of GAAP diluted EPS to adjusted diluted EPS in the press release filed as Exhibit 99.1 on February 6, 2026.
- Monitor upcoming regulatory changes regarding the Affordable Care Act (ACA) and enhanced advance premium tax credits.
- Assess the company's ability to maintain CMS Star ratings and manage medical cost trends in the current inflationary environment.
- Review the company's exposure to government payor rate cuts and contract renewal terms.
- Confirm the status of any ongoing legal or regulatory investigations mentioned in recent 10-K or 10-Q filings.